panaxytriol has been researched along with Nerve Degeneration in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halim, M; Sames, D; Yee, DJ | 1 |
1 other study(ies) available for panaxytriol and Nerve Degeneration
| Article | Year |
|---|---|
Imaging induction of cytoprotective enzymes in intact human cells: coumberone, a metabolic reporter for human AKR1C enzymes reveals activation by panaxytriol, an active component of red ginseng.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Animals; Antineoplastic Agents; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Cytoprotection; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enediynes; Enzyme Activation; Enzyme Induction; Fatty Alcohols; Fluorescent Dyes; Heterocyclic Compounds, 4 or More Rings; Humans; Hydroxyprostaglandin Dehydrogenases; Hydroxysteroid Dehydrogenases; Indomethacin; Microscopy, Fluorescence; Models, Biological; Molecular Structure; Nerve Degeneration; Neuroprotective Agents; Panax; Sensitivity and Specificity; Up-Regulation; Ursodeoxycholic Acid | 2008 |